Sin Yun Jin Ashley, MacLeod Rebecca, Tanguay Adam P, Wang Andrew, Braender-Carr Olivia, Vitelli Teraesa M, Jay Gregory D, Schmidt Tannin A, Cowman Mary K
Department of Biomedical Engineering, Tandon School of Engineering, New York University, New York, NY, United States.
Department of Biomedical Engineering, School of Dental Medicine, UConn Health, Farmington, CT, United States.
Front Mol Biosci. 2022 Oct 5;9:990861. doi: 10.3389/fmolb.2022.990861. eCollection 2022.
The size, conformation, and organization of the glycosaminoglycan hyaluronan (HA) affect its interactions with soluble and cell surface-bound proteins. HA that is induced to form stable networks has unique biological properties relative to unmodified soluble HA. AlphaLISA assay technology offers a facile and general experimental approach to assay protein-mediated networking of HA in solution. Connections formed between two end-biotinylated 50 kDa HA (bHA) chains can be detected by signal arising from streptavidin-coated donor and acceptor beads being brought into close proximity when the bHA chains are bridged by proteins. We observed that incubation of bHA with the protein TSG-6 (tumor necrosis factor alpha stimulated gene/protein 6, TNFAIP/TSG-6) leads to dimerization or higher order multimerization of HA chains in solution. We compared two different heparin (HP) samples and two heparan sulfate (HS) samples for the ability to disrupt HA crosslinking by TSG-6. Both HP samples had approximately three sulfates per disaccharide, and both were effective in inhibiting HA crosslinking by TSG-6. HS with a relatively high degree of sulfation (1.75 per disaccharide) also inhibited TSG-6 mediated HA networking, while HS with a lower degree of sulfation (0.75 per disaccharide) was less effective. We further identified Proteoglycan 4 (PRG4, lubricin) as a TSG-6 ligand, and found it to inhibit TSG-6-mediated HA crosslinking. The effects of HP, HS, and PRG4 on HA crosslinking by TSG-6 were shown to be due to HP/HS/PRG4 inhibition of HA binding to the Link domain of TSG-6. Using the AlphaLISA platform, we also tested other HA-binding proteins for ability to create HA networks. The G1 domain of versican (VG1) effectively networked bHA in solution but required a higher concentration than TSG-6. Cartilage link protein (HAPLN1) and the HA binding protein segment of aggrecan (HABP, G1-IGD-G2) showed only low and variable magnitude HA networking effects. This study unambiguously demonstrates HA crosslinking in solution by TSG-6 and VG1 proteins, and establishes PRG4, HP and highly sulfated HS as modulators of TSG-6 mediated HA crosslinking.
糖胺聚糖透明质酸(HA)的大小、构象和组织会影响其与可溶性及细胞表面结合蛋白的相互作用。相对于未修饰的可溶性HA,诱导形成稳定网络的HA具有独特的生物学特性。AlphaLISA检测技术提供了一种简便通用的实验方法,用于检测溶液中蛋白质介导的HA网络化。当生物素化的50 kDa HA(bHA)链被蛋白质桥接时,链霉亲和素包被的供体珠和受体珠紧密靠近会产生信号,从而检测到两条末端生物素化的bHA链之间形成的连接。我们观察到bHA与蛋白TSG-6(肿瘤坏死因子α刺激基因/蛋白6,TNFAIP/TSG-6)孵育会导致溶液中HA链二聚化或形成更高阶的多聚体。我们比较了两种不同的肝素(HP)样品和两种硫酸乙酰肝素(HS)样品破坏TSG-6介导的HA交联的能力。两种HP样品每二糖约有三个硫酸根,二者均能有效抑制TSG-6介导的HA交联。硫酸化程度相对较高(每二糖1.75个)的HS也能抑制TSG-6介导的HA网络化,而硫酸化程度较低(每二糖0.75个)的HS效果较差。我们进一步鉴定出蛋白聚糖4(PRG4,润滑素)是TSG-6的配体,并发现它能抑制TSG-6介导的HA交联。结果表明,HP、HS和PRG4对TSG-6介导的HA交联的影响是由于HP/HS/PRG4抑制了HA与TSG-6连接域的结合。利用AlphaLISA平台,我们还测试了其他HA结合蛋白形成HA网络的能力。多功能蛋白聚糖(VG1)的G1结构域能有效使溶液中的bHA网络化,但所需浓度高于TSG-6。软骨连接蛋白(HAPLN1)和聚集蛋白聚糖的HA结合蛋白片段(HABP,G1-IGD-G2)仅表现出低且变化的HA网络化效应。本研究明确证明了TSG-6和VG1蛋白在溶液中使HA交联,并确定PRG4、HP和高度硫酸化的HS是TSG-6介导的HA交联的调节剂。